BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21622216)

  • 1. Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease.
    Kakizaki S; Takizawa D; Tojima H; Horiguchi N; Yamazaki Y; Mori M
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):2988-3005. PubMed ID: 21622216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease.
    Kakizaki S; Takizawa D; Tojima H; Yamazaki Y; Mori M
    Curr Drug Targets; 2009 Nov; 10(11):1156-1163. PubMed ID: 19925451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the nuclear receptors FXR, PXR and CAR in normal and cholestatic placenta.
    Geenes VL; Dixon PH; Chambers J; Raguz S; Marin JJ; Bhakoo KK; Williamson C
    Placenta; 2011 Jul; 32(7):535-7. PubMed ID: 21596433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Aspects in the Management of Cholestatic Liver Diseases.
    Chazouillères O
    Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.
    Beuers U; Trauner M; Jansen P; Poupon R
    J Hepatol; 2015 Apr; 62(1 Suppl):S25-37. PubMed ID: 25920087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of PXR and CAR in cholestasis].
    Suh JI
    Korean J Hepatol; 2006 Mar; 12(1):5-15. PubMed ID: 16565602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptors as drug targets in cholestatic liver diseases.
    Halilbasic E; Baghdasaryan A; Trauner M
    Clin Liver Dis; 2013 May; 17(2):161-89. PubMed ID: 23540496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane X receptor as a therapeutic target for cholestatic liver injury.
    Lan H; Zhang Y; Fan M; Wu B; Wang C
    Drug Metab Rev; 2023 Nov; 55(4):371-387. PubMed ID: 37593784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?
    Beuers U; Kullak-Ublick GA; Pusl T; Rauws ER; Rust C
    Clin Rev Allergy Immunol; 2009 Feb; 36(1):52-61. PubMed ID: 18751930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.
    Reschly EJ; Krasowski MD
    Curr Drug Metab; 2006 May; 7(4):349-65. PubMed ID: 16724925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the pregnane X receptor: how to fight one aggressor with two strategies.
    Rust C; Beuers U
    Liver Int; 2010 Feb; 30(2):161-3. PubMed ID: 20456034
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
    Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
    J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The xenobiotic receptors PXR and CAR in liver physiology, an update.
    Cai X; Young GM; Xie W
    Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166101. PubMed ID: 33600998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PXR- and CAR-mediated herbal effect on human diseases.
    Xu C; Huang M; Bi H
    Biochim Biophys Acta; 2016 Sep; 1859(9):1121-1129. PubMed ID: 26906544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and emerging therapies for cholestatic liver diseases.
    Goldstein J; Levy C
    Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting FXR in Cholestasis.
    Keitel V; Dröge C; Häussinger D
    Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
    Kim KH; Choi JM; Li F; Arizpe A; Wooton-Kee CR; Anakk S; Jung SY; Finegold MJ; Moore DD
    Endocrinology; 2018 Jun; 159(6):2435-2446. PubMed ID: 29718219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors.
    Luisier R; Lempiäinen H; Scherbichler N; Braeuning A; Geissler M; Dubost V; Müller A; Scheer N; Chibout SD; Hara H; Picard F; Theil D; Couttet P; Vitobello A; Grenet O; Grasl-Kraupp B; Ellinger-Ziegelbauer H; Thomson JP; Meehan RR; Elcombe CR; Henderson CJ; Wolf CR; Schwarz M; Moulin P; Terranova R; Moggs JG
    Toxicol Sci; 2014 Jun; 139(2):501-11. PubMed ID: 24690595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
    Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
    J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.